Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of donor characteristics on T cell replete haploidentical stem cell transplantation
ChiCTR2100049939Phase 2Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of antithymocyte globulin rabbit in hematopoietic malignancies, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Overall survival. Started Aug 2021; status: recruiting.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on ChiCTR2100049939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049939.